Chicago Capital, LLC Sage Therapeutics, Inc. Transaction History

Chicago Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 14, 2020	SELL	$60.18 - $154.77 $5.48 Million - $14.1 Million	-91,051 Closed	0 $0
Q3 2019 Oct 29, 2019	BUY	$140.29 - $189.96 $2.47 Million - $3.35 Million	17,612 Added 23.98%	91,051 $12.8 Million
Q2 2019 Jul 11, 2019	BUY	$157.85 - $183.09 $65,665 - $76,165	416 Added 0.57%	73,439 $13.4 Million
Q1 2019 Apr 23, 2019	BUY	$89.33 - $163.65 $3.74 Million - $6.85 Million	41,850 Added 134.25%	73,023 $11.6 Million
Q4 2018 Feb 11, 2019	BUY	$81.94 - $139.71 $2.55 Million - $4.36 Million	31,173 New	31,173 $2.99 Million

198

46.5M

402K

209K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $326M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Chicago Capital, LLC with notifications on news.